Drug intelligence / Profile preview

shenlingcao

Development stage
Phase 4
Lead developer
Hong Kong Baptist University
Modality
Small Molecules
Administration
Oral
01

Overview

Shenlingcao is a traditional Chinese herbal medicine formulation marketed as "Shenlingcao oral liquid." It is used primarily as a complementary therapy to improve quality of life and reduce fatigue in patients with conditions such as long COVID-associated fatigue and non-small cell lung cancer (NSCLC) undergoing adjuvant chemotherapy. The formulation contains American Ginseng (Panacis Quinquefolii Radix), Lucid Ganoderma (Ganoderma), Rose (Rosae Rugosae Flos), and fermented Cordyceps powder. Clinical trials have shown that it can improve physical, role, and emotional function scores in NSCLC patients receiving chemotherapy, as well as alleviate symptoms like fatigue, nausea/vomiting, appetite loss, and performance status over a 6-month follow-up period. Its mechanism of action is not fully elucidated but may involve immunomodulatory effects[1][2][3][4][7].

Brand names
Shenlingcao oral liquid
Other names
Shenlingcao oral solutionShenlingcao oral liquid

Beyond the preview

Go deeper on shenlingcao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shenlingcao.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call